Cerebral angiography is an imaging technique used to visualize the arteries and veins of the brain and neck. Cerebral angiography helps diagnose problems such as narrowed or bulging arteries, growths on arteries or veins, abnormalities of blood vessels and clots. It allows detailed pictures of the blood vessels supplying the brain and neck. The procedure is performed using a catheter that is inserted into an artery, usually in the groin or arm, and threaded through the blood vessels to the brain. Contrast dye is then injected through the catheter so that the blood vessels can be seen on x-rays and images are taken rapidly.

The global cerebral angiography market is estimated to be valued at US$ 17.24 Bn  in 2024 and is expected to exhibit a CAGR of 8.8% over the forecast period 2024 to 2030. Key factors driving the growth of the market include rising prevalence of stroke and brain aneurysm, increasing aging population and technological advancements. Rising cases of neurological disorders and growing demand for minimally invasive surgical procedures are also fueling market growth.

Key Takeaways
Key players operating in the Global Cerebral Angiography Market Size are Kyowa Hakko Bio Co., Ltd., Shandong Jincheng Biological Pharmaceutical Co., Ltd., KOHJIN Life Sciences Co., Ltd., Shenzhen GSH Bio-Technology Co, Ltd, Kaiping Genuine Biochemical Pharmaceutical Co., Ltd., Nissor Pharmaceuticals Ltd., and Jarrow Formulas, Inc. These players are focusing on geographic expansion and new product launches.

The increasing prevalence of neurological disorders like stroke, brain aneurysms is driving the growth of the cerebral angiography market. According to WHO, every year 15 million people suffer from stroke globally. Technological advancements in angiography like flat panel detector angiography systems and 3D angiography systems allow high-quality images with better visualization.

Advancements in angiography technologies like digital subtraction angiography(DSA) systems, CT angiography, and magnetic resonance angiography(MRA) allow non-invasive accurate diagnosis of neurovascular disorders, fueling market growth.

Market Trends
Increasing adoption of flat panel detector (FDD) C-arms - Flat panel detector C-arms provide high-resolution X-ray images and have replaced image intensifier-based C-arms. They eliminate image distortion and are compact, allowing flexibility to perform angiography exams effectively.
Growing demand for non-invasive angiography techniques - Minimally invasive angiography techniques like CT angiography (CTA) and MR angiography (MRA) are gaining popularity as they do not require arterial catheterization and use non-ionizing radiation. CTA allows 3D reconstruction of images and MRA provides high soft tissue contrast without using contrast agents.

Market Opportunities
Untapped emerging markets - Emerging markets in Asia Pacific and Latin America have large patient pools but lack requisite healthcare infrastructure and access to quality care. This presents lucrative opportunities for market players.
Innovations in AI and analytics - Application of AI and machine learning can make angiography more accurate by automating tasks like image noise removal, segmentation, vessel enhancement etc. It can help detect anomalies that human reviewers may miss.

Impact of COVID-19 on Cerebral Angiography Market Growth

The COVID-19 pandemic has significantly impacted the growth of the global cerebral angiography market. During the initial outbreak, most of the non-emergency medical procedures were postponed to minimize the risks of transmitting the virus. This disrupted the demand for cerebral angiography procedures. As cerebral angiography is a minimally invasive brain imaging technique used to diagnose and treat various brain-related disorders such as aneurysms, arteriovenous malformations, etc. The cancelled procedures hampered the market growth in 2020.

However, as the pandemic situation improved with effective vaccination programs in 2021, the demand gradually revived. With increased awareness about the procedure's benefits, healthcare facilities resumed normal operation by following strict safety protocols. This has helped the market to regain momentum. Still, concerns regarding virus transmission in hospitals continue to pose challenges. Market players are innovating novel portable angiography systems to enable healthcare providers conduct the procedures outside dedicated operating rooms safely. Affordability of treatment is also a major factor influencing the post-pandemic recovery and future growth prospects.

The North America region dominates the global cerebral angiography market in terms of value. Large patient pool suffering from neurological disorders, advanced healthcare infrastructure, sophisticated reimbursement policies, and presence of leading market players drive the regional market growth. The United States accounts for the major share owing to high preference for minimally invasive surgeries and availability of reimbursement.

The Asia Pacific region is identified as the fastest growing market for cerebral angiography. Rising geriatric population susceptible to neurological conditions, improving diagnostic capabilities, growing medical tourism, and increasing healthcare expenditures are fueling the regional market demand. Furthermore, expanding private health insurance penetration is also supporting the market expansion. Countries such as China, India, and Japan are expected to showcase high growth rates during the forecast period.

Get More Insights On This Topic: Cerebral Angiography Market

Explore More Article: Germany Nutritional Supplements